,trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['destiny study', 'breast']
 this is how oncologists around the world are celebrating the promising results of the destiny study, demonstrating the effectiveness of a new chemotherapy regimen for unresectable breast cancer. wow! chicago, #asco conference, 2022 
American abstract artist